Structure

Physi-Chem Properties

Molecular Weight:  306.05
Volume:  297.325
LogP:  4.37
LogD:  3.026
LogS:  -6.647
# Rotatable Bonds:  1
TPSA:  61.81
# H-Bond Aceptor:  5
# H-Bond Donor:  0
# Rings:  5
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.533
Synthetic Accessibility Score:  2.468
Fsp3:  0.056
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.711
MDCK Permeability:  3.8030957512091845e-05
Pgp-inhibitor:  0.816
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  0.006
30% Bioavailability (F30%):  0.927

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.004
Plasma Protein Binding (PPB):  94.2674331665039%
Volume Distribution (VD):  0.816
Pgp-substrate:  5.4679131507873535%

ADMET: Metabolism

CYP1A2-inhibitor:  0.992
CYP1A2-substrate:  0.175
CYP2C19-inhibitor:  0.913
CYP2C19-substrate:  0.066
CYP2C9-inhibitor:  0.594
CYP2C9-substrate:  0.924
CYP2D6-inhibitor:  0.937
CYP2D6-substrate:  0.933
CYP3A4-inhibitor:  0.921
CYP3A4-substrate:  0.141

ADMET: Excretion

Clearance (CL):  9.883
Half-life (T1/2):  0.125

ADMET: Toxicity

hERG Blockers:  0.026
Human Hepatotoxicity (H-HT):  0.236
Drug-inuced Liver Injury (DILI):  0.958
AMES Toxicity:  0.272
Rat Oral Acute Toxicity:  0.306
Maximum Recommended Daily Dose:  0.381
Skin Sensitization:  0.105
Carcinogencity:  0.94
Eye Corrosion:  0.003
Eye Irritation:  0.425
Respiratory Toxicity:  0.789

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC167479

Natural Product ID:  NPC167479
Common Name*:   Pongaglabrone
IUPAC Name:   2-(1,3-benzodioxol-5-yl)furo[2,3-h]chromen-4-one
Synonyms:   Pongaglabrone
Standard InCHIKey:  OLRNTGNFKYRPHW-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C18H10O5/c19-13-8-16(10-1-3-15-17(7-10)22-9-21-15)23-18-11(13)2-4-14-12(18)5-6-20-14/h1-8H,9H2
SMILES:  c1cc2c(cc1c1cc(=O)c3ccc4c(cco4)c3o1)OCO2
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL583961
PubChem CID:   10957726
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001615] Flavones
          • [CHEMONTID:0001759] Furanoflavones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO30165 Pongamia pinnata Species Fabaceae Eukaryota stem bark Indonesia 1999-SEP PMID[14510596]
NPO30165 Pongamia pinnata Species Fabaceae Eukaryota n.a. stem n.a. PMID[14510596]
NPO3037 Derris indica Species Fabaceae Eukaryota root n.a. n.a. PMID[19515570]
NPO30165 Pongamia pinnata Species Fabaceae Eukaryota dry stem n.a. n.a. PMID[25466192]
NPO30165 Pongamia pinnata Species Fabaceae Eukaryota Roots n.a. n.a. PMID[29482940]
NPO30165 Pongamia pinnata Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO2398 Millettia erythrocalyx Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO2398 Millettia erythrocalyx Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO2398 Millettia erythrocalyx Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT34 Cell Line BV-2 Mus musculus IC50 = 45670.0 nM PMID[531336]
NPT1604 Individual Protein Cytochrome P450 1B1 Homo sapiens IC50 = 6800.0 nM PMID[531337]
NPT1603 Individual Protein Cytochrome P450 1A1 Homo sapiens IC50 = 6400.0 nM PMID[531337]
NPT1604 Individual Protein Cytochrome P450 1B1 Homo sapiens IC50 = 3400.0 nM PMID[531337]
NPT1603 Individual Protein Cytochrome P450 1A1 Homo sapiens IC50 = 8200.0 nM PMID[531337]
NPT2 Others Unspecified IC50 = 8.6 % PMID[531335]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC167479 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9937 High Similarity NPC41853
0.9752 High Similarity NPC62640
0.9571 High Similarity NPC66804
0.9568 High Similarity NPC157522
0.9509 High Similarity NPC72455
0.9317 High Similarity NPC65846
0.9114 High Similarity NPC130015
0.9114 High Similarity NPC38361
0.9096 High Similarity NPC475964
0.9074 High Similarity NPC109238
0.9024 High Similarity NPC187923
0.9024 High Similarity NPC38914
0.9006 High Similarity NPC310206
0.9 High Similarity NPC233776
0.8994 High Similarity NPC68882
0.8988 High Similarity NPC290304
0.8988 High Similarity NPC236327
0.8987 High Similarity NPC135303
0.8987 High Similarity NPC148423
0.8981 High Similarity NPC306788
0.8976 High Similarity NPC211309
0.8963 High Similarity NPC110257
0.8957 High Similarity NPC34376
0.8957 High Similarity NPC264293
0.8951 High Similarity NPC113055
0.8944 High Similarity NPC155063
0.8931 High Similarity NPC472407
0.8922 High Similarity NPC190351
0.8916 High Similarity NPC241820
0.8902 High Similarity NPC18284
0.8902 High Similarity NPC273021
0.8882 High Similarity NPC478238
0.8875 High Similarity NPC153008
0.8875 High Similarity NPC148497
0.8875 High Similarity NPC292460
0.8834 High Similarity NPC250076
0.8827 High Similarity NPC261484
0.8827 High Similarity NPC261090
0.882 High Similarity NPC478213
0.882 High Similarity NPC244371
0.882 High Similarity NPC41719
0.882 High Similarity NPC279930
0.8797 High Similarity NPC198427
0.8788 High Similarity NPC302741
0.878 High Similarity NPC131557
0.878 High Similarity NPC243509
0.8773 High Similarity NPC258644
0.8773 High Similarity NPC82733
0.8773 High Similarity NPC76458
0.8765 High Similarity NPC3273
0.8765 High Similarity NPC284353
0.8743 High Similarity NPC67450
0.8743 High Similarity NPC210460
0.8743 High Similarity NPC193881
0.8743 High Similarity NPC155264
0.8735 High Similarity NPC179464
0.8734 High Similarity NPC190572
0.8727 High Similarity NPC304387
0.8727 High Similarity NPC94155
0.8727 High Similarity NPC216092
0.872 High Similarity NPC33320
0.872 High Similarity NPC15764
0.8704 High Similarity NPC57211
0.8698 High Similarity NPC131866
0.8696 High Similarity NPC279061
0.8675 High Similarity NPC234536
0.8675 High Similarity NPC478199
0.8675 High Similarity NPC19948
0.8675 High Similarity NPC125991
0.8675 High Similarity NPC78612
0.8675 High Similarity NPC193998
0.8671 High Similarity NPC224687
0.8667 High Similarity NPC139876
0.8659 High Similarity NPC19097
0.8655 High Similarity NPC469601
0.8642 High Similarity NPC52623
0.8642 High Similarity NPC263676
0.8642 High Similarity NPC253872
0.8642 High Similarity NPC104728
0.8642 High Similarity NPC35544
0.8634 High Similarity NPC472406
0.8614 High Similarity NPC99968
0.8614 High Similarity NPC296540
0.8614 High Similarity NPC309335
0.8606 High Similarity NPC215375
0.8606 High Similarity NPC257914
0.8606 High Similarity NPC62518
0.8606 High Similarity NPC238405
0.8606 High Similarity NPC104459
0.858 High Similarity NPC116604
0.8571 High Similarity NPC179015
0.8571 High Similarity NPC173149
0.8571 High Similarity NPC88445
0.8555 High Similarity NPC469600
0.8554 High Similarity NPC19554
0.8554 High Similarity NPC269906
0.8554 High Similarity NPC43971
0.8554 High Similarity NPC285973
0.8554 High Similarity NPC225624
0.8554 High Similarity NPC74749
0.8553 High Similarity NPC136278
0.8553 High Similarity NPC296575
0.8553 High Similarity NPC471590
0.8545 High Similarity NPC167595
0.8539 High Similarity NPC60848
0.8538 High Similarity NPC223375
0.8538 High Similarity NPC475825
0.8528 High Similarity NPC40033
0.8519 High Similarity NPC189270
0.8519 High Similarity NPC5840
0.8519 High Similarity NPC191104
0.8512 High Similarity NPC470178
0.8509 High Similarity NPC476342
0.8506 High Similarity NPC183843
0.8506 High Similarity NPC104682
0.8503 High Similarity NPC260640
0.8503 High Similarity NPC295009
0.8503 High Similarity NPC162668
0.8491 Intermediate Similarity NPC113089
0.8488 Intermediate Similarity NPC233956
0.8488 Intermediate Similarity NPC277510
0.8488 Intermediate Similarity NPC310794
0.8485 Intermediate Similarity NPC45131
0.8485 Intermediate Similarity NPC301897
0.848 Intermediate Similarity NPC144288
0.848 Intermediate Similarity NPC135370
0.8476 Intermediate Similarity NPC472408
0.8476 Intermediate Similarity NPC128961
0.8476 Intermediate Similarity NPC186507
0.8475 Intermediate Similarity NPC73703
0.8471 Intermediate Similarity NPC247973
0.8462 Intermediate Similarity NPC470773
0.8462 Intermediate Similarity NPC300053
0.8452 Intermediate Similarity NPC219861
0.8452 Intermediate Similarity NPC469575
0.8447 Intermediate Similarity NPC74539
0.8447 Intermediate Similarity NPC304443
0.8447 Intermediate Similarity NPC205522
0.8443 Intermediate Similarity NPC220582
0.8443 Intermediate Similarity NPC78944
0.8443 Intermediate Similarity NPC298093
0.8443 Intermediate Similarity NPC304839
0.8439 Intermediate Similarity NPC472607
0.8438 Intermediate Similarity NPC246903
0.843 Intermediate Similarity NPC248593
0.843 Intermediate Similarity NPC28589
0.8428 Intermediate Similarity NPC9966
0.8428 Intermediate Similarity NPC476054
0.8428 Intermediate Similarity NPC70853
0.8424 Intermediate Similarity NPC278010
0.8424 Intermediate Similarity NPC250769
0.8424 Intermediate Similarity NPC295608
0.8421 Intermediate Similarity NPC471287
0.8415 Intermediate Similarity NPC166201
0.8412 Intermediate Similarity NPC277480
0.8412 Intermediate Similarity NPC119589
0.8412 Intermediate Similarity NPC113093
0.8402 Intermediate Similarity NPC470772
0.8402 Intermediate Similarity NPC15819
0.8395 Intermediate Similarity NPC63256
0.8395 Intermediate Similarity NPC10304
0.8393 Intermediate Similarity NPC15212
0.8393 Intermediate Similarity NPC258331
0.8393 Intermediate Similarity NPC188486
0.8393 Intermediate Similarity NPC470756
0.8391 Intermediate Similarity NPC156635
0.8391 Intermediate Similarity NPC325176
0.8391 Intermediate Similarity NPC107244
0.8385 Intermediate Similarity NPC231013
0.8385 Intermediate Similarity NPC216314
0.8385 Intermediate Similarity NPC120924
0.8385 Intermediate Similarity NPC14958
0.8385 Intermediate Similarity NPC106461
0.8385 Intermediate Similarity NPC40818
0.8385 Intermediate Similarity NPC110639
0.8385 Intermediate Similarity NPC215932
0.8385 Intermediate Similarity NPC195919
0.8383 Intermediate Similarity NPC16935
0.8383 Intermediate Similarity NPC196879
0.8383 Intermediate Similarity NPC50430
0.8383 Intermediate Similarity NPC125713
0.8375 Intermediate Similarity NPC17262
0.8375 Intermediate Similarity NPC293201
0.8373 Intermediate Similarity NPC470625
0.8373 Intermediate Similarity NPC180340
0.8373 Intermediate Similarity NPC472461
0.8372 Intermediate Similarity NPC281835
0.8372 Intermediate Similarity NPC212748
0.8372 Intermediate Similarity NPC51404
0.8365 Intermediate Similarity NPC29536
0.8365 Intermediate Similarity NPC185607
0.8364 Intermediate Similarity NPC472462
0.8364 Intermediate Similarity NPC131725
0.8363 Intermediate Similarity NPC320789
0.8363 Intermediate Similarity NPC42892
0.8363 Intermediate Similarity NPC471288
0.8363 Intermediate Similarity NPC135345
0.8354 Intermediate Similarity NPC170169
0.8353 Intermediate Similarity NPC37183
0.8353 Intermediate Similarity NPC165720

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC167479 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8957 High Similarity NPD1247 Approved
0.872 High Similarity NPD919 Approved
0.858 High Similarity NPD3818 Discontinued
0.8447 Intermediate Similarity NPD920 Approved
0.8443 Intermediate Similarity NPD5494 Approved
0.8438 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.8382 Intermediate Similarity NPD6559 Discontinued
0.8313 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.8221 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.8187 Intermediate Similarity NPD3926 Phase 2
0.8095 Intermediate Similarity NPD3817 Phase 2
0.8084 Intermediate Similarity NPD1934 Approved
0.8047 Intermediate Similarity NPD3882 Suspended
0.8036 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8036 Intermediate Similarity NPD2801 Approved
0.8012 Intermediate Similarity NPD1243 Approved
0.8 Intermediate Similarity NPD7054 Approved
0.8 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7955 Intermediate Similarity NPD7472 Approved
0.7955 Intermediate Similarity NPD7074 Phase 3
0.7937 Intermediate Similarity NPD2796 Approved
0.7927 Intermediate Similarity NPD1511 Approved
0.7921 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7831 Intermediate Similarity NPD1512 Approved
0.7821 Intermediate Similarity NPD7808 Phase 3
0.7816 Intermediate Similarity NPD6232 Discontinued
0.7811 Intermediate Similarity NPD7411 Suspended
0.7809 Intermediate Similarity NPD6797 Phase 2
0.7784 Intermediate Similarity NPD7473 Discontinued
0.7771 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7765 Intermediate Similarity NPD7251 Discontinued
0.7751 Intermediate Similarity NPD4380 Phase 2
0.7733 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7727 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7727 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7727 Intermediate Similarity NPD6166 Phase 2
0.7719 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7719 Intermediate Similarity NPD7819 Suspended
0.7697 Intermediate Similarity NPD5844 Phase 1
0.7697 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7688 Intermediate Similarity NPD3749 Approved
0.7661 Intermediate Similarity NPD6801 Discontinued
0.7657 Intermediate Similarity NPD7199 Phase 2
0.7654 Intermediate Similarity NPD1510 Phase 2
0.7622 Intermediate Similarity NPD1549 Phase 2
0.7605 Intermediate Similarity NPD6799 Approved
0.7605 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7586 Intermediate Similarity NPD7075 Discontinued
0.7578 Intermediate Similarity NPD1933 Approved
0.7572 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7571 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.756 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7529 Intermediate Similarity NPD4966 Approved
0.7529 Intermediate Similarity NPD4967 Phase 2
0.7529 Intermediate Similarity NPD4965 Approved
0.7528 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7471 Intermediate Similarity NPD5402 Approved
0.747 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7443 Intermediate Similarity NPD6234 Discontinued
0.7442 Intermediate Similarity NPD6599 Discontinued
0.7439 Intermediate Similarity NPD3748 Approved
0.7414 Intermediate Similarity NPD1465 Phase 2
0.736 Intermediate Similarity NPD6959 Discontinued
0.7356 Intermediate Similarity NPD37 Approved
0.7353 Intermediate Similarity NPD5401 Approved
0.7349 Intermediate Similarity NPD2344 Approved
0.7349 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7348 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.733 Intermediate Similarity NPD7768 Phase 2
0.7322 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7301 Intermediate Similarity NPD1240 Approved
0.7289 Intermediate Similarity NPD1551 Phase 2
0.7287 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7284 Intermediate Similarity NPD2313 Discontinued
0.7283 Intermediate Similarity NPD3226 Approved
0.7267 Intermediate Similarity NPD5403 Approved
0.7262 Intermediate Similarity NPD2800 Approved
0.7253 Intermediate Similarity NPD3751 Discontinued
0.7251 Intermediate Similarity NPD2533 Approved
0.7251 Intermediate Similarity NPD2532 Approved
0.7251 Intermediate Similarity NPD2534 Approved
0.7246 Intermediate Similarity NPD1471 Phase 3
0.7219 Intermediate Similarity NPD3750 Approved
0.7219 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD1607 Approved
0.7195 Intermediate Similarity NPD943 Approved
0.7181 Intermediate Similarity NPD8434 Phase 2
0.7176 Intermediate Similarity NPD2309 Approved
0.7158 Intermediate Similarity NPD7228 Approved
0.7152 Intermediate Similarity NPD447 Suspended
0.7151 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD5005 Approved
0.7143 Intermediate Similarity NPD5006 Approved
0.7128 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7128 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7127 Intermediate Similarity NPD3787 Discontinued
0.7127 Intermediate Similarity NPD6808 Phase 2
0.7112 Intermediate Similarity NPD8313 Approved
0.7112 Intermediate Similarity NPD8312 Approved
0.7101 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7088 Intermediate Similarity NPD5242 Approved
0.7083 Intermediate Similarity NPD2935 Discontinued
0.7049 Intermediate Similarity NPD2403 Approved
0.7048 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7044 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7041 Intermediate Similarity NPD2346 Discontinued
0.7033 Intermediate Similarity NPD7229 Phase 3
0.7031 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7029 Intermediate Similarity NPD1653 Approved
0.7026 Intermediate Similarity NPD4420 Approved
0.7024 Intermediate Similarity NPD2799 Discontinued
0.7005 Intermediate Similarity NPD7240 Approved
0.697 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6968 Remote Similarity NPD4419 Clinical (unspecified phase)
0.6966 Remote Similarity NPD6280 Approved
0.6966 Remote Similarity NPD6279 Approved
0.6952 Remote Similarity NPD5953 Discontinued
0.6951 Remote Similarity NPD6832 Phase 2
0.6946 Remote Similarity NPD230 Phase 1
0.6935 Remote Similarity NPD7286 Phase 2
0.6933 Remote Similarity NPD2798 Approved
0.6931 Remote Similarity NPD8151 Discontinued
0.6927 Remote Similarity NPD8455 Phase 2
0.6915 Remote Similarity NPD7685 Pre-registration
0.691 Remote Similarity NPD6386 Approved
0.691 Remote Similarity NPD6385 Approved
0.6893 Remote Similarity NPD7458 Discontinued
0.6889 Remote Similarity NPD5353 Approved
0.6886 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6886 Remote Similarity NPD1613 Approved
0.6882 Remote Similarity NPD2163 Approved
0.6871 Remote Similarity NPD3266 Approved
0.6871 Remote Similarity NPD3267 Approved
0.6851 Remote Similarity NPD5019 Clinical (unspecified phase)
0.6848 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6839 Remote Similarity NPD4287 Approved
0.6833 Remote Similarity NPD5760 Phase 2
0.6833 Remote Similarity NPD5761 Phase 2
0.6832 Remote Similarity NPD7584 Approved
0.6824 Remote Similarity NPD1509 Clinical (unspecified phase)
0.6821 Remote Similarity NPD4628 Phase 3
0.6816 Remote Similarity NPD5889 Approved
0.6816 Remote Similarity NPD5890 Approved
0.6788 Remote Similarity NPD9494 Approved
0.6788 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6784 Remote Similarity NPD6779 Approved
0.6784 Remote Similarity NPD6780 Approved
0.6784 Remote Similarity NPD6777 Approved
0.6784 Remote Similarity NPD6781 Approved
0.6784 Remote Similarity NPD6782 Approved
0.6784 Remote Similarity NPD6776 Approved
0.6784 Remote Similarity NPD6778 Approved
0.6763 Remote Similarity NPD2654 Approved
0.6761 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6757 Remote Similarity NPD5711 Approved
0.6757 Remote Similarity NPD5710 Approved
0.6733 Remote Similarity NPD7871 Phase 2
0.6733 Remote Similarity NPD7870 Phase 2
0.6728 Remote Similarity NPD3705 Approved
0.6725 Remote Similarity NPD651 Clinical (unspecified phase)
0.6719 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6717 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6712 Remote Similarity NPD4846 Phase 2
0.6705 Remote Similarity NPD7390 Discontinued
0.6704 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6703 Remote Similarity NPD5616 Clinical (unspecified phase)
0.6703 Remote Similarity NPD2296 Approved
0.6699 Remote Similarity NPD7782 Clinical (unspecified phase)
0.6699 Remote Similarity NPD7783 Phase 2
0.6686 Remote Similarity NPD4307 Phase 2
0.6684 Remote Similarity NPD7784 Clinical (unspecified phase)
0.6683 Remote Similarity NPD7435 Discontinued
0.6683 Remote Similarity NPD7696 Phase 3
0.6683 Remote Similarity NPD7698 Approved
0.6683 Remote Similarity NPD7697 Approved
0.6667 Remote Similarity NPD6585 Discontinued
0.6667 Remote Similarity NPD1296 Phase 2
0.6667 Remote Similarity NPD7028 Phase 2
0.6667 Remote Similarity NPD1203 Approved
0.6667 Remote Similarity NPD3268 Approved
0.6667 Remote Similarity NPD7422 Clinical (unspecified phase)
0.665 Remote Similarity NPD8285 Discontinued
0.6628 Remote Similarity NPD7033 Discontinued
0.6627 Remote Similarity NPD1019 Discontinued
0.6625 Remote Similarity NPD5536 Phase 2
0.6612 Remote Similarity NPD4288 Approved
0.6608 Remote Similarity NPD6651 Approved
0.6607 Remote Similarity NPD3027 Phase 3
0.6605 Remote Similarity NPD17 Approved
0.6601 Remote Similarity NPD7680 Approved
0.6591 Remote Similarity NPD6190 Approved
0.6583 Remote Similarity NPD4362 Clinical (unspecified phase)
0.6583 Remote Similarity NPD4361 Phase 2
0.6568 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6568 Remote Similarity NPD3764 Approved
0.6566 Remote Similarity NPD1049 Clinical (unspecified phase)
0.6562 Remote Similarity NPD6764 Approved
0.6562 Remote Similarity NPD6765 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data